CMAX CEO and COO Join AusBiotech’s Advisory Groups!
We’re thrilled to share that our CEO, Jane Kelly, has been re-elected as a member of AusBiotech’s Clinical Trials Advisory Group, and our COO, Jennifer Kaczorowski, has been elected for the Workforce Advisory Group!
At CMAX, we're proud to support AusBiotech's mission of ...
Stellar Award Winner - Outstanding Partnership
What a privilege it is to win the Stellar Award for Outstanding Partnership!
The Southern Star Research Awards initiative recognises and celebrates site partners who demonstrate excellence across collaboration, communication, quality and delivery ...
CMAX Joins The NZCR Family!
We are thrilled to embark on an exciting new chapter as we join the New Zealand Clinical Research (NZCR) family, forming Australasia’s largest independent, multi-phase clinical research organisation.
With shared core values and a strong track record of success, we couldn’t be happier with this partnership and look forward to advancing tomorrow’s healthcare together ...
Winners of the National Professional Services Export Award!
What an honour it is to win the Professional Services Award at the 63rd Australian Exports Awards! Congratulations to all nominees and a special mention to the Australian Trade and Investment Commission (Austrade) for recognising outstanding work across our Nation ...
A CMAX SUCCESS STORY!
We’re incredibly proud to celebrate another major milestone in early-phase clinical research at CMAX - one that brings real hope to children living with epilepsy.
Our Principal Investigator Sepehr Shakib and the committed CMAX team conducted the first-ever human trial of Relutrigine, a potential ...
Appointment of Our New Chief Operations Officer
We are thrilled to announce the appointment of Jennifer Kaczorowski as our new Chief Operations Officer!
Jennifer brings a wealth of experience and expertise to CMAX. With a proven track record of driving operational excellence ...
A CMAX SUCCESS STORY!
We’re beyond proud to announce a remarkable early-phase clinical trial achievement at CMAX - one that brings fresh hope to patients around the world!
In 2017, our very own Principal Investigator Professor Sepehr Shakib and the dedicated CMAX team conducted the first-ever human trial of NPI-001, a potential new treatment for Retinitis Pigmentosa...
WINNERS OF THE PROFESSIONAL SERVICES EXPORT AWARD!
We are thrilled to announce that we have won the Professional Services Award at the SA Premier's Business and Export Awards!
We congratulate fellow award winners and thank our amazing team at CMAX - without your endless hard work and dedication, moments like these wouldn’t be possible.
Global Demand Fuels Record Growth For CMAX
One of Australia’s largest clinical trial providers, CMAX, has entered the strongest growth phase in its 31-year history propelled by increasing global demand.
The Adelaide-based company reported 20 per cent revenue growth over the past year with export sales to key international markets China and the United States rising by 86 per cent and 44 per cent respectively.
About cmax
With more than 30 years of experience, CMAX is one of Australia’s largest early phase clinical trial facilities. When conducting trials, participant safety is paramount.
Centrally positioned in Adelaide, CMAX is located adjacent to The Royal Adelaide Hospital in South Australia's innovative Bio-Med City precinct.